The burden of seizure emergencies in spain: a systematic literature review
INTRODUCTION: Seizure emergencies pose significant clinical and healthcare challenges in Spain, impacting morbidity, mortality, and resource utilization. Comprehensive data on epidemiology, clinical outcomes, and economic impact remain limited. METHODS: A systematic review was conducted following the Centre for Reviews and Dissemination (CRD), Cochrane, and Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines. Embase, PubMed, and CINAHL were searched (January 2010-April 2025) for observational studies on epileptic seizure emergencies in Spain. Study selection, data extraction, and risk of bias assessment (ROBINS-I) were performed independently by two reviewers. Given reporting heterogeneity, a descriptive narrative synthesis was undertaken. RESULTS: Forty-seven observational studies identified 16 population groups. The analysis focuses on two groups with the most comprehensive data: status epilepticus (SE), epileptic seizures at the emergency department; and in pediatric populations. SE patients experienced extended seizure duration (8-51 h), in-hospital mortality averaging 24.3%, intensive care unit (ICU) admissions between 17% and 48%, and hospital stays up to 24 days, indicating substantial resource utilization. Patients with epileptic seizures at the emergency department exhibited hospitalization rates between 6-32% and medical complications between 19.4% and 52.1%. Pre-hospital benzodiazepines use was between 11 and 38%. Pediatric likely underrepresented populations had lower mortality but frequent emergency visits. No studies assessed quality of life or indirect costs; one reported direct cost in SE. CONCLUSION: Reporting of seizure emergencies in Spain is heterogeneous and biased toward severe cases, likely overestimating per-patient burden while underestimating population impact. Broader data capture and improved early management could inform planning and reduce overall burden.
Authors
- Malena Águila-Fuentes (ORCID: https://orcid.org/0000-0002-6654-4516)
- C Martin Saborido (ORCID: https://orcid.org/0000-0002-3969-6768)
- Irene Lizano‐Díez (ORCID: https://orcid.org/0000-0002-5729-5968)
- María Torrejón
- Navid Behzadi Koochani (ORCID: https://orcid.org/0000-0003-3817-2783)
- Félix González Martínez
- Marc Manau
- Noem Sain
- Roberto Ciordia Dominguez
- Jessica Cruz
- Patricia Smeyers Durá
- Manuel Toledo
Institutions
- Hebron University (PS)
- University of Alicante (ES)
- Hospital Universitari i Politècnic La Fe (ES)
- Department of Health and Aged Care (AU)
- Directorate of Health (IS)
- Hospital Universitario de Torrejón (ES)
- Hospital Virgen de la Luz (ES)
- Institute of Agrifood Research and Technology (ES)
- Madrid Health Service (ES)
- Vall d'Hebron Hospital Universitari (ES)
- Agencia de Evaluación de Tecnologías Sanitarias (ES)
- UCB Pharma (Belgium) (BE)
Publication Details
- Journal
- Epilepsy & Behavior
- Published
- 2026-05-01
- DOI
- https://doi.org/10.1016/j.yebeh.2026.111056
- Primary Topic
- Epilepsy research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00